Min Gu

No ORCID on file · 1 paper in corpus

lab-animal 2018

TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways

Cell death & disease ·doi:10.1038/s41419-017-0197-y

Hormone therapy drugs, such as bicalutamide and enzalutamide, directed against prostate cancer focus on androgen receptor (AR) signaling and are initially effective, but the disease progresses to lethality as resistance to these drugs devel…